Modeling new approaches for controlling breast cancer
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum
This study is looking at new ways to better manage breast cancer by understanding different risk factors, like having type 2 diabetes, and aims to find the best screening and treatment methods to help improve survival rates and reduce differences in outcomes among different racial groups.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10907446 on NIH RePORTER |
What this research studies
This research investigates innovative modeling techniques to improve breast cancer control by analyzing various risk factors, including comorbidities like type 2 diabetes. It aims to evaluate the effectiveness of precision screening and treatment strategies, focusing on how these can reduce breast cancer mortality and address racial disparities in outcomes. By utilizing advanced models from multiple institutions, the research seeks to provide evidence-based recommendations for clinical practices and policies that enhance patient care and survival rates.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for breast cancer, particularly those with comorbidities like type 2 diabetes or those from racial minority groups disproportionately affected by breast cancer.
Not a fit: Patients with non-breast cancer conditions or those who do not have risk factors for breast cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized breast cancer screening and treatment options, ultimately improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown success in using modeling approaches to improve cancer control strategies, indicating that this methodology is both promising and relevant.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Trentham-Dietz, Amy — University of Wisconsin-Madison
- Study coordinator: Trentham-Dietz, Amy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.